|
Dosing schedule for ZEN-3694
|
6
|
Zenith Epigenetics
|
Jul 13, 2016 05:10PM
|
|
Re: Esperion news, has this been discussed?
|
6
|
Resverlogix Corp.
|
Jan 15, 2019 11:00AM
|
|
Re: BETonMACE Enrollment
|
6
|
Resverlogix Corp.
|
Aug 29, 2017 08:00AM
|
|
Re: What would a successful BETonMACE Top-Line Data Announcement Look Like?
|
6
|
Resverlogix Corp.
|
Aug 11, 2019 02:08PM
|
|
Re: Primary endpoint: Time vs Absolute Numbers
|
6
|
Resverlogix Corp.
|
Nov 19, 2018 12:27PM
|
|
Re: Two ways to accumulate?
|
6
|
Resverlogix Corp.
|
Sep 16, 2016 12:44PM
|
|
Re: Estimated Glomerular Filtration Rate
|
6
|
Resverlogix Corp.
|
Nov 17, 2019 06:53PM
|
|
Re: ZEN-3694 and Enzalutamide 2b Trial
|
6
|
Zenith Epigenetics
|
Apr 22, 2021 04:31PM
|
|
Two investor conferences May 2
|
6
|
Resverlogix Corp.
|
Apr 30, 2016 05:43PM
|
|
Re: Resverlogix Closes Extension of Maturity Date of Loan and Announces Private Placement
|
6
|
Resverlogix Corp.
|
Sep 05, 2017 10:27AM
|
|
Re: What would a successful BETonMACE Top-Line Data Announcement Look Like?
|
6
|
Resverlogix Corp.
|
Aug 11, 2019 02:37PM
|
|
Re: Agm
|
6
|
Resverlogix Corp.
|
Dec 13, 2017 12:01PM
|
|
Re: NIH Halts Large Cardiovascular Inflammation Reduction Trial (CIRT)
|
6
|
Resverlogix Corp.
|
Sep 22, 2018 10:58AM
|
|
Re: Zenith AGM Corporation Update Slides and Webcast
|
6
|
Zenith Epigenetics
|
Nov 20, 2019 11:46AM
|
|
Re: The countdown to 250
|
6
|
Resverlogix Corp.
|
Oct 10, 2018 04:32PM
|
|
Re: 250 MACE scenario question
|
6
|
Resverlogix Corp.
|
Jan 24, 2019 07:44PM
|
|
Re: Bio Investor Forum October 20-21st; BETonMACE announcement?
|
6
|
Resverlogix Corp.
|
Oct 13, 2015 09:29PM
|
|
Re: Presentation
|
6
|
Resverlogix Corp.
|
Oct 24, 2020 12:12PM
|
|
Re: #Covid19 Interview of Nevan Krogan, PDF of article
|
6
|
Resverlogix Corp.
|
Mar 27, 2020 10:37AM
|
|
Re: China offering fast marketing approvals
|
6
|
Resverlogix Corp.
|
Aug 10, 2018 04:38PM
|
